28.4: Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.

Diagnostic Assessments:

1. The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.

• Prerenal causes, such as dehydration, hypotension, or blood loss, should be suspected when there’s a history of fluid loss or low blood pressure.
• Intrarenal causes, such as exposure to nephrotoxic drugs like aminoglycosides or contrast media, can lead to direct kidney injury.
• Postrenal causes are usually linked to urinary obstructions, such as kidney stones, benign prostatic hyperplasia (BPH), or tumors.

2. Diagnostic markers such as serum creatinine and urine output are well-established, but they often reflect kidney injury late in the course of AKI. Serum creatinine may not increase until more than 50% of kidney function is lost. The rate of increase in creatinine helps assess the severity of the injury.
3. Urinalysis is an essential tool in distinguishing AKI causes. In prerenal and postrenal cases, urine sediment is typically normal. However, intrarenal AKI may reveal hematuria, pyuria, and the presence of casts or crystals, indicating tubular damage or infection.
4. Imaging studies are also crucial. A renal ultrasound is the first-line imaging tool to assess the kidneys without exposing the patient to contrast agents. It helps detect anatomical abnormalities or urinary obstructions. In more complex cases, a CT scan can reveal masses, lesions, or vascular abnormalities. For intrarenal causes of AKI, a renal biopsy is often necessary to provide a definitive diagnosis.

Prevention of AKI:

1. Preventing AKI begins with identifying at-risk patients, such as those with chronic kidney disease (CKD), diabetes, heart failure, or the elderly, particularly those undergoing surgery or diagnostic procedures involving contrast agents.
2. Hydration with intravenous (IV) normal saline before and after procedures is the most effective strategy to prevent contrast-induced nephropathy. N-acetylcysteine, previously recommended for preventing contrast-induced AKI, is no longer considered effective.
3. Monitoring kidney function is crucial in patients on nephrotoxic drugs, such as NSAIDs or aminoglycosides. For patients with heart failure or cirrhosis, NSAID use increases the risk of kidney injury, and dosage should be adjusted accordingly. Avoiding nephrotoxic medications and reducing exposure to contrast agents is essential in high-risk patients.
4. Infections should be promptly treated, as they can accelerate kidney damage. Careful attention should also be given to preventing catheter-related urinary infections by removing catheters as soon as possible. Regular monitoring of urine output, serum electrolytes, and fluid balance is vital to early detection and management of AKI.